Chirurgia mininvasiva vs approccio posteriore standard nel trattamento della scoliosi idiopatica dell’età evolutiva: studio randomizzato

Title

Code

MISpro

Type

Sperimentale

Start Year

2022

Status

In Corso

Principal Investigator

alessandro.gasbarrini@ior.it

Gasbarrini Alessandro, MD

Director

Spine Surgery

Operational unit that carry out the study

complex unit

Chirurgia Vertebrale

Director

Gasbarrini Alessandro, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio clinico prot. MISpro

Friday 18 November 2022, 14:13

PG0016715_2022_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Chirurgia mininvasiva vs approccio posteriore standard nel trattamento della scoliosi idiopatica dell’età evolutiva: studio randomizzato

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Chirurgia mininvasiva vs approccio posteriore standard nel trattamento della scoliosi idiopatica dell’età evolutiva: studio randomizzato

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in